Evidence map›Paper›PMID 10706638›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes.

D Cue, S O Southern, P J Southern, J Prabhakar, W Lorelli, J M Smallheer, S A Mousa, P P Cleary

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 99 citations in OpenAlex.

  1. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  2. Review
  3. Article
  4. Role of serotype and virulence determinants ofFrontiers in cellular and infection microbiology · 2023
    Article
  5. AssessingFrontiers in cellular and infection microbiology · 2022
    Article
  6. Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Intracellular Invasion byMicrobiology spectrum · 2019
    Review
  11. Review
  12. Article
  13. Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  14. Article
  15. Review
  16. Review
  17. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2008
    Article
  18. Review
  19. Article
  20. Streptococcal modulation of cellular invasion via TGF-beta1 signaling.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

D CueDepartment of Microbiology, University of Minnesota, Minneapolis, MN 55455, USA.
S O Southern
P J Southern
J Prabhakar
W Lorelli
J M Smallheer
S A Mousa
P P Cleary
Experimental Station · USUniversity of Minnesota · US

Funding

INTRACELLULAR INFECTION BY INVASIVE GROUP A STREPTOCOCCIR01AI034503 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CLEARY, PAUL PATRICK · 1995 to 2006
$1.1M
NIAID NIH HHS AI34503NIAID NIH HHS R01 AI034503
6 · The paper itself

Abstract

Streptococcus pyogenes can be efficiently internalized by a variety of human epithelial cells. beta-lactam antibiotics, commonly used to treat S. pyogenes infections, do not readily permeate mammalian cells. There is growing evidence that the ability of streptococci to enter host cells contributes to the frequent failure of antibiotics to eradicate the organism from infected individuals. Recent studies have suggested that host cell entry requires the formation of a complex of a bacterial fibronectin (Fn) binding protein (e.g., M1 protein or protein F1/SfbI), human Fn, and the epithelial cell Fn receptor, integrin alpha5beta1. We report here that a low molecular weight, nonpeptide antagonist of integrin alpha5beta1, SJ755, can inhibit internalization of streptococci by primary human tonsillar epithelial cells and immortalized human epithelial (A549) cells, thus increasing the extent of bacterial killing by antibiotics. SJ755 blocked Fn binding by human tonsillar epithelial and A549 cells, suggesting that integrin alpha5beta1 is the major Fn receptor expressed by both cell types. SJ755 did not affect Fn binding by purified M1 protein or M1(+) bacteria. Purified M1 protein failed to associate with integrin alpha5beta1 unless the integrin had been prebound by Fn. Also, SJ755 blocked formation of alpha5beta1-Fn-M1 complexes in vitro. These results support the previous proposal that Fn functions as a molecular bridge between M1 protein and integrin alpha5beta1. Furthermore, these results suggest that integrin antagonists may enhance the efficacy of antibiotics in treatment of S. pyogenes infections.

Indexed as

Adhesins, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsBenzimidazolesCarrier ProteinsCell AdhesionCell LineDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayEpithelial CellsFibronectinsHumansIntegrinsModels, BiologicalPalatine TonsilAdhesins, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsBenzimidazolesCarrier Proteinsfibronectin-binding proteins, bacterialFibronectinsIntegrinsPeptidesReceptors, FibronectinSJ 755Spiro Compoundsstreptococcal M protein

Identifiers

PMID10706638
PMCPMC16020
OpenAlexW2023901812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.